Abstract

Introduction Raynaud's phenomenon (RP) is a multifactorial disorder. If any underlying disease cannot be determined to be responsible for RP, then it is considered to be the primary RP (pRP). We aimed to investigate the differences between laboratory markers and impaired endothelial function in pRP. Materials and Methods Forty-two pRP patients and 30 healthy individuals were included as the study and control groups, respectively. The endothelial function was evaluated with flow-mediated dilatation (FMD) of the brachial artery. The blood samples were obtained from both groups, and white blood cell (WBC), hemoglobin, platelets, mean platelet volume (MPV), creatinine, alanine aminotransferase (ALT), aspartate aminotransferase (AST), D-dimer, fibrinogen, albumin, fibrinogen-to-albumin ratio (FAR), neutrophil-to-lymphocyte ratio (NLR), D-dimer-to-albumin ratio (DDAR), and monocyte chemoattractant protein-1 (MCP-1) parameters were studied. The blood parameters and FMD values obtained were compared between groups. Results The groups were similar in regard to age, gender, and smoking history (p < 0.05). There was no difference between the two groups in regard to hemoglobin, platelet, MPV, creatinine, ALT, D-dimer, albumin, FAR, NLR, and DDAR levels (p < 0.05). AST levels were slightly higher in the pRP group (p=0.027). Markedly increased WBC, fibrinogen, MPV, and MCP-1 values were detected in the pRP group (p=0.001), as well as higher abnormal FMD responses (p=0.001). There was a direct correlation between abnormal FMD response and serum MCP-1 values in patients with pRP (R: 0.308, R2: 0.095, p: 0.044). Conclusion It seems to be that MCP-1 levels are higher in patients with pRP, and increased values of MCP-1 levels seem to be related to impaired endothelial functions.

Highlights

  • Raynaud’s phenomenon (RP) is a multifactorial disorder

  • Our results have indicated that patients with primary RP (pRP) have a higher impaired endothelial response to ischemia and the incremental levels of serum white blood cell (WBC), mean platelet volume (MPV), monocyte chemoattractant protein-1 (MCP-1), and fibrinogen values were detected in the pRP group

  • Routine laboratory parameters (white blood cell (WBC) (10−3/uL), hemoglobin (g/dL), platelet (10−3/uL), mean platelet volume (MPV), creatinine, alanine aminotransferase (ALT) (IU/L), aspartate aminotransferase (AST) (IU/L), D-dimer, fibrinogen, albumin (g/dL), fibrinogen-to-albumin ratio (FAR) (%), neutrophil-to-lymphocyte ratio (NLR) (%), D-dimer-to-albumin ratio (DDAR) (%), and monocyte chemoattractant protein-1 (MCP-1) levels were studied from the acquired serum samples. e commercially available human MCP-1 ELISA kit (SUNLONG, Sun Long Biotech Co., LTD) was used for determining MCP-1 levels (SUNLONG) as described in previous reports [11]

Read more

Summary

Introduction

Raynaud’s phenomenon (RP) is a multifactorial disorder. If any underlying disease cannot be determined to be responsible for RP, it is considered to be the primary RP (pRP). Increased WBC, fibrinogen, MPV, and MCP-1 values were detected in the pRP group (p 0.001), as well as higher abnormal FMD responses (p 0.001). It seems to be that MCP-1 levels are higher in patients with pRP, and increased values of MCP-1 levels seem to be related to impaired endothelial functions. E disorder can be related to traumas or microtraumas resulting from prolonged usage of vibratory tools, exposure to some chemicals, and autoimmune rheumatic or connective tissue diseases, such as systemic sclerosis. If it progresses, it can result in digital ulcers or microamputations [1–3]. There is no autoimmunity-associated marker or reaction and a comprehensive anamnesis should be taken and a physical and laboratory examination should be performed in every case of RP, since after excluding suspected pathologies, the RP cases are often classified as primary type [1, 5]

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call